Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
NCT03504956Recruiting
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Jul 2018
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Open-label trial (2 arms), sponsored by Cedars-Sinai Medical Center. Primary endpoint: Plaque to Myocardial Ratio at Day 1. Started Jul 2018; status: recruiting.
Beyond the preview
Go deeper on NCT03504956.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03504956.